BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 20374337)

  • 41. Nasal extranodal natural killer T cell lymphoma: an atypical presentation.
    Sharma A; Dandekar M; Deshmukh S; Dabholkar J
    J Laryngol Otol; 2011 Nov; 125(11):1181-4. PubMed ID: 21733277
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Spontaneous regression of natural killer cell lymphoma.
    Isobe Y; Aritaka N; Sasaki M; Oshimi K; Sugimoto K
    J Clin Pathol; 2009 Jul; 62(7):647-50. PubMed ID: 19561234
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.
    Guo Y; Lu JJ; Ma X; Wang B; Hong X; Li X; Li J
    Oral Oncol; 2008 Jan; 44(1):23-30. PubMed ID: 17306611
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Late diagnosis: a case of rapidly progressive extranodal NK/T cell lymphoma, nasal type.
    Mori H; Ebisawa K; Nishimura M; Kanazawa K
    BMJ Case Rep; 2018 Feb; 2018():. PubMed ID: 29455176
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MRI appearances of stage IE/IIE extranodal NK/T-cell lymphoma, nasal type, in the upper aerodigestive tract.
    Gu Y; Wu B; Zhang Y; Guo Y; Peng W
    Eur Rev Med Pharmacol Sci; 2014; 18(3):404-12. PubMed ID: 24563442
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy.
    Lee J; Park YH; Kim WS; Lee SS; Ryoo BY; Yang SH; Park KW; Kang JH; Park JO; Lee SH; Kim K; Jung CW; Park YS; Im YH; Kang WK; Lee MH; Ko YH; Ahn YC; Park K
    Eur J Cancer; 2005 Jul; 41(10):1402-8. PubMed ID: 15963893
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lethal T- and NK-cell lymphomas mimicking granulomatous panniculitidies: a clinicopathologic study of three cases.
    Chow KF; Ritchie E; Husain S; Alobeid B; Bhagat G
    J Cutan Pathol; 2011 Jun; 38(6):483-91. PubMed ID: 21375563
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Analysis of clinicopathological features and prognostic factors of 62 nasal NK/T-cell lymphomas].
    Xu G; Wang H; Xie K; He G; Du Z
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Oct; 21(20):932-4. PubMed ID: 18254324
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nasal natural killer/T-cell lymphoma.
    Lin CY; Cheng PW
    Otolaryngol Head Neck Surg; 2010 Sep; 143(3):461-2. PubMed ID: 20723790
    [No Abstract]   [Full Text] [Related]  

  • 50. First report of primary pancreatic natural killer/T-cell nasal type lymphoma.
    Liu W; Hua R; Zhang JF; Huo YM; Liu DJ; Sun YW
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17(3):318-22. PubMed ID: 23426534
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Extranodal NK/T-Cell Lymphoma, Nasal Type-Case Report of 2 Cases.
    Neves Cavada M; Silveira Martha A; Sgarabotto Pezzin L; Mazzaferro Krebs J; Mazzini Steffen L; Schultz Maahs G
    Ear Nose Throat J; 2020 Sep; 99(8):NP91-NP93. PubMed ID: 31170821
    [No Abstract]   [Full Text] [Related]  

  • 52. Extranodal NK/T-cell lymphoma, nasal type extensively involving the bone marrow.
    Rezk SA; Huang Q
    Int J Clin Exp Pathol; 2011; 4(7):713-7. PubMed ID: 22076172
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal Nk/T-cell lymphoma, nasal type.
    Nakashima Y; Tagawa H; Suzuki R; Karnan S; Karube K; Ohshima K; Muta K; Nawata H; Morishima Y; Nakamura S; Seto M
    Genes Chromosomes Cancer; 2005 Nov; 44(3):247-55. PubMed ID: 16049916
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Extra-nodal NK/T-cell lymphoma, nasal-type, revealed by cutaneous and ocular involvement].
    Marzouki-Zerouali A; Charbit L; Mitcov M; Violon F; Schmutz JL; Moawad S; Bursztejn AC
    Ann Dermatol Venereol; 2019 Oct; 146(10):626-633. PubMed ID: 31371036
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Advances in the management and monitoring of extranodal NK/T-cell lymphoma, nasal type.
    Liang R
    Br J Haematol; 2009 Oct; 147(1):13-21. PubMed ID: 19604234
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The simultaneous appearance of a nasal natural killer-cell lymphoma and acute myelogenous leukemia.
    Van Crombrugge L; De Vos G; Vanclooster C; Lemmerling M; Kerre T
    B-ENT; 2012; 8(1):49-52. PubMed ID: 22545391
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Nasal NK/T lymphoma. A case report].
    Ladeb S; Gaulard P; Ben Othmen T; Abd Alsamad I; Delfau-Larue MH; Abdelkefi A; Torjmen L; Ben Abdeladhim A
    Ann Pathol; 2003 Apr; 23(2):149-52. PubMed ID: 12843969
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nasal-type NK/T-cell lymphoma: a case report.
    Tiodorović J; Lazarević V; Binić I; Tiodorović-Zivković D
    Acta Dermatovenerol Alp Pannonica Adriat; 2007 Jun; 16(2):73-6. PubMed ID: 17992462
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Extranodal nasal-type natural killer/T-cell lymphoma of the skin: a clinicopathologic study of 16 cases in China.
    Yu JB; Zuo Z; Tang Y; Zhao S; Zhang YC; Bi CF; Wang WY; Zhang WY; Wang L; Liu WP
    Hum Pathol; 2009 Jun; 40(6):807-16. PubMed ID: 19200574
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The enhanced expression of the matrix metalloproteinase 9 in nasal NK/T-cell lymphoma.
    Sakata K; Someya M; Omatsu M; Asanuma H; Hasegawa T; Ichimiya S; Hareyama M; Himi T
    BMC Cancer; 2007 Dec; 7():229. PubMed ID: 18093334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.